Pulmonary vascular disease for the general respiratory clinician

Breathe (Sheff). 2022 Dec;18(4):220261. doi: 10.1183/20734735.0261-2022. Epub 2022 Dec 13.

Abstract

Pulmonary vascular disease is relevant to many practising respiratory clinicians: ∼1% of the world's population is estimated to have PH, and it is an important consequence of many other respiratory diseases (e.g. COPD, ILD, sleep breathing disorders) https://bit.ly/3hLqUx1.

Publication types

  • Editorial
  • Comment